Adcock Ingram Pharma Private Limited - Company Profile

It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 2021.
2021 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Adcock Ingram Pharma Private Limited

Adcock Ingram Pharma Private Limited, a active private limited company, was established on 07 June 2021 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299KA2021PTC148184. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹71.46 Cr and a paid-up capital of ₹71.46 Cr.

It upholds a compliant status. Employing 67 professional, Its leadership includes Pravin Vaidyanathan Iyer (Director), Pankaj Garg (Director), Yasuhiro Nakagiri (Director). Past directors included Gundala Ramireddy, Pravin Vaidyanathan Iyer, Pankaj Garg. It holds ₹58.00 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 41/42, Bommasandra Industrial Area Anekal Taluk, Bengaluru, Karnataka, 560099.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299KA2021PTC148184

  • Registration Number

    148184

  • Incorporation Date

    07 June 2021

  • Authorized Capital

    ₹71.46 Cr

  • Paid-Up Capital

    ₹71.46 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 71.46 Cr
  • Paid Up Capital ₹ 71.46 Cr
  • Company Age 4 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 58.00 Cr
  • Revenue Growth **** -88.45%
  • Profit Growth **** -344.67%
  • Ebitda **** -10.01%
  • Net Worth 107.11%
  • Total Assets **** 108.86%
Company report

Adcock Ingram Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Adcock Ingram Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Adcock Ingram Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Pravin Vaidyanathan Iyer Director 07 Jun 2021 Current
Pankaj Garg Director 07 Jun 2021 Current
Yasuhiro Nakagiri Director 08 May 2024 Current
Ammanna Chowdary Yarlagadda Managing Director 21 Sep 2022 Current
Yudhveer Singh Director 24 Jan 2022 Current
Kenshi Murase Director 11 Jun 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 28 Mar 2022 Past
Pramod Abcsdd Director 27 Sep 2022 Past
Pramod Abcsdd Director 27 Sep 2022 Past
Pramod Abcsdd Additional Director 27 Sep 2024 Past
Pramod Abcsdd Director 12 Feb 2025 Past
Pramod Abcsdd Additional Director 21 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Adcock Ingram Pharma.

Adcock Ingram Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 88.45% decrease. The company also saw a substantial fall in profitability, with a 344.67% decrease in profit. The company's net worth Soared by an impressive increase of 107.11%.

Adcock Ingram Pharma revenue growth over time
Adcock Ingram Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -88.45%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 108.86%
*******
*******
*******
*******
Profit or Loss
*******
 -344.67%
*******
*******
*******
*******
Net Worth
*******
 107.11%
*******
*******
*******
*******
EBITDA
*******
 -10.01%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Adcock Ingram Pharma?

In 2023, Adcock Ingram Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹580,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 58.00 Cr
Latest Charge Details
Date Lender Amount Status
08 Mar 2022 Others ₹58.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Adcock Ingram Pharma?

Adcock Ingram Pharma has a workforce of 67 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Adcock Ingram Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adcock Ingram Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Adcock Ingram Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Adcock Ingram Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Adcock Ingram Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Director Appointment

    Dorette Neethling was appointed as a Director was appointed as a Director on 19 Feb 2025 & has been associated with this company since 1 year 11 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 58.00 Cr registered on 08 Mar 2022 with Charge ID 100553591 was modified on 30 Dec 2024. was documented.

  • Director Appointment

    The activity Yasuhiro Nakagiri was appointed as a Director was appointed as a Director on 08 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Director Appointment

    Progress on Ammanna Chowdary Yarlagadda was appointed as a Managing Director was appointed as a Managing Director on 21 Sep 2022 & has been associated with this company since 3 years 5 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Adcock Ingram Pharma Private Limited?

The CIN of Adcock Ingram Pharma Private Limited is U24299KA2021PTC148184.

Where is Adcock Ingram Pharma Private Limited headquartered?

Adcock Ingram Pharma Private Limited is headquartered at 41/42, Bommasandra Industrial Area Anekal Taluk, Bengaluru, Karnataka, 560099.

When was Adcock Ingram Pharma Private Limited incorporated?

Adcock Ingram Pharma Private Limited was incorporated on 07 June 2021.

Who are the current directors of Adcock Ingram Pharma Private Limited?

The current directors of Adcock Ingram Pharma Private Limited are

What is the primary industry of Adcock Ingram Pharma Private Limited?

The primary industry of Adcock Ingram Pharma Private Limited is Manufacturing.

Is Adcock Ingram Pharma Private Limited a listed company?

Adcock Ingram Pharma Private Limited is unlisted.

What is the capital structure of Adcock Ingram Pharma Private Limited?

The authorized capital of Adcock Ingram Pharma Private Limited is ₹71.46 Cr, and the paid-up capital is ₹71.46 Cr.

What is the compliance status of Adcock Ingram Pharma Private Limited?

The compliance status of Adcock Ingram Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available